Form 4 for TRLV Trulieve Cannabis Corp.
Accepted 2023-07-27 00:00:00 ET · period of report 2023-07-25 · accession 0001209191-23-043600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-27 | 2023-07-25 | TRLV | Landrum Kyle | Chief Production Off | A - Grant | $0.00 | +57.5K | 88.5K | +186% | $0 |
| D | 2023-07-27 | 2023-07-25 | TRLV | Landrum Kyle | Chief Production Off | A - Grant | $0.00 | +128.0K | 128.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2023-07-25 | A | A | 57,515 | $0.00 | 88,475 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-07-25 | A | A | 127,986 | $0.00 | 127,986 | D | $6.52 · — to 2030-07-24 | 127,986 Subordinate Voting Shares | (F2) The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2023, one-third vesting on December 1, 2024, and one-third vesting on December 1, 2025. |